Maximize Your R&D Tax Credits in 2025
The R&D tax credit represents one of the most valuable and underutilized incentives available to innovation companies. Whether you're an early-stage biotech startup offsetting payroll taxes or an established technology company optimizing federal and state credits, proper planning ensures you capture every dollar available while maintaining audit-ready documentation.
Our team of CPAs specializes in R&D tax credit strategy for companies engaged in qualified research activities—from drug development and clinical trials to software development and manufacturing process improvements.

6 Tax Strategies We Explore for Early-Stage R&D Companies
1. R&D Tax Credits Used to Offset Payroll Taxes
Early-stage R&D companies are generally eligible for tax credits based on their qualified research expenses. Since early-stage companies rarely have taxable income to utilize these credits, they can instead elect to utilize them as an offset against payroll taxes. With a limit of up to $500,000 per year for up to five years, that is a potential cumulative tax savings of up to $2.5 million.
2. Costs Eligible for the R&D Tax Credit
Wages of R&D employees, R&D contractor expenses (at a discounted 65% rate), and supplies used in R&D are among the most common of the costs eligible for the credit. Notably, only domestic costs are eligible, so be sure to exclude any R&D done by employees or contactors overseas.
3. Tax Structure
It is important to select the most appropriate tax structure for your business. Many early-stage companies organize as an LLC for simplicity, but later look to convert to a corporation. Filing as a C-corporation provides a unique opportunity for 1202 Qualified Small Business Stock (QSBS) status, which has substantial tax benefits when you sell your shares. Furthermore, investors expect their portfolio companies to be structured as Corporations for legal purposes. It is important to understand all the legal and tax options available to determine which option is best for you.
4. 1202 Qualified Small Business Stock (QSBS)
Section 1202 encourages investment in small businesses. When investors hold QSBS for at least five years they are eligible to exclude up to $10 million of gain from their income tax return ($15 million for stock issued after July 4th, 2025). However, to ensure this huge tax advantage is secured there are specific requirements that must be met.
QSBS stock must be acquired directly from the C-corporation, either purchased for cash or exchanged for property or services. QSBS purchased from another person loses its QSBS status. A notable exception is when received as a gift.
To be considered a Qualified small business the corporations aggregate gross assets must not exceed $50 million ($75 million for stock issued after July 4th, 2025) at any point prior to or immediately after the issuance of the stock.
Certain businesses are not eligible for 1202 stock exclusions, such as those in health, law, engineering, accounting, consulting, banking, farming, to name a few. However, companies engaged in startup and R&D activities that provide products or services to those companies are still eligible for 1202 stock exclusion.
5. Sales & Use Tax Exemptions
Many states offer sales and use tax exemptions when purchasing equipment used in R&D activities. It is important to be aware if your state has an exemption and the rules for utilizing that exemption. For R&D startups, this exemption can be a big money saver which can make all the difference!
6. Bonus Depreciation
The One Big Beautiful Bill Act (OBBBA) restored the full and immediate deduction (often referred to as bonus depreciation) of all equipment purchased after January 19th, 2025. This provision generally covers all furniture, computers, equipment, leasehold improvements, and much more. This provision allows the tax deduction timing to match cash outflows and prevent unnecessary income tax bills for companies.
Our team of CPAs are here to assist with optimizing your tax strategy, please use the link below to schedule a call to learn more.
“We’ve had the pleasure of working with the accounting team at Eva Garland Consulting, and Chris Gearing has been a standout partner throughout the process. From onboarding our new accounting team to supporting us as we scale, Chris and his team have been instrumental in helping us stay organized, compliant, and confident in our operations.”
Nicole Librandi, Accounting Manager
“I’ve had a great experience working with Eva Garland Consulting for our accounting needs at Clearsens. Their team is knowledgeable, responsive, and highly experienced in handling accounting for SBIR/STTR-funded companies.”
Yalcin Yamaner, CEO
“Had a great experience with EGC supporting our ARPA-E grant financial reporting!”
Jacob Grose, CEO & Co-Founder
“EGC accounting provided what I so value (and admire) in a relationship, clear and honest communication – regardless of how the client might receive the information. Thank you.”
Scott Miller, Co-Founder
“EGC has been a blessing for Mycologics not only for proposal preparation but also for grant management. It would be impossible to run and manage the company’s R&D activities as a solo founder with 2 federal grants and 1 state grant without their support. I cannot emphasize enough how grateful I am!”
Anindya Chanda, Ph.D., Founder and CEO
“The service provided by EGC is much better than what we received from a local CPA with much less knowledge about grant management.”
Hieu Le Mau
“Getting into this I had no understanding of the accounting needs that a start-up would require. EGC has guided me through the whole process and ensured we stay compliant with accounting and tax requirements.”
Stephen Duncan, Ph.D., Founder
“Working with Eva Garland has been one of the best accounts management and compliance decisions for our early stage company and award management. Their streamlined process makes it very simple for us to keep track of all of our needs, and we continue to seek advice for all new actions that need to be taken.”
Ishita M. Shah, Ph.D., CEO and Co-Founder
“I feel very confident that we will be meeting the highest standard of compliance with government regulations for our grant. We appreciate the level of detail and focus from the compliance team.”
Sheana, President and Co-Founder
“You have been instrumental from setting up the accounting system to educating us on federal regulations. Couldn’t have done it without you. We look forward to working with you and Keith going forward.”
Nora Yang, PhD, CEO
“We have been working with Eva Garland Consulting (EGC) for three years now and our experience has been great. The team at EGC is extremely knowledgeable in government grant compliance and has always been very responsive to our questions and requests. I would recommend EGC to anyone looking for government grant compliance and accounting services.”
Chenming Chang, PhD, Co-Founder
“We had tried several accounting firms before EGC but none understood SBIR/STTR funding. EGC has been a godsend to us.”
Raj Shekhar
Accelerating development of innovative technologies
EGC's team of scientists and accountants work exclusively with R&D companies, providing integrated grant funding, accounting, and tax services. Our deep expertise in the innovation ecosystem allows us to deliver strategic tax planning that aligns with your funding strategy and business objectives.